Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

被引：0

作者：

Shunichi Sugawara

Kazuhiko Nakagawa

Nobuyuki Yamamoto

Hiroshi Nokihara

Yuichiro Ohe

Makoto Nishio

Toshiaki Takahashi

Koichi Goto

Makoto Maemondo

Yukito Ichinose

Takashi Seto

Hiroshi Sakai

Akihiko Gemma

Fumio Imamura

Masato Shingyoji

Hideo Saka

Akira Inoue

Koji Takeda

Isamu Okamoto

Katsuyuki Kiura

Satoshi Morita

Tomohide Tamura

机构：

[1] Sendai Kousei Hospital,Department of Pulmonary Medicine

[2] Kindai University,Department of Medical Oncology, Faculty of Medicine

[3] Wakayama Medical University,Third Department of Internal Medicine

[4] National Cancer Center Hospital,Department of Thoracic Oncology

[5] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Thoracic Medical Oncology

[6] Shizuoka Cancer Center,Division of Thoracic Oncology

[7] National Cancer Center Hospital East,Department of Thoracic Oncology

[8] Miyagi Cancer Center,Department of Respiratory Medicine

[9] Clinical Research Institute,Department of Cancer Information Research, National Kyushu Cancer Center

[10] National Kyushu Cancer Center,Department of Thoracic Oncology

[11] Saitama Cancer Center,Department of Thoracic Oncology

[12] Nippon Medical School,Department of Pulmonary Medicine and Oncology, Graduate School of Medicine

[13] Osaka International Cancer Institute,Department of Thoracic Oncology

[14] Chiba Cancer Center,Division of Respirology

[15] National Hospital Organization Nagoya Medical Center,Department of Respiratory Medicine and Medical Oncology

[16] Tohoku University School of Medicine,Department of Palliative Medicine

[17] Osaka City General Hospital,Department of Medical Oncology

[18] Kyushu University,Research Institute for Diseases of the Chest, Graduate School of Medical Sciences

[19] Okayama University Graduate School of Medicine,Department of Hematology, Oncology, and Respiratory Medicine

[20] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics

[21] St Luke’s International Hospital,Thoracic Center

来源：

International Journal of Clinical Oncology | 2019年 / 24卷

关键词：

Tegafur–gimeracil–oteracil; Second line; Third line; Chemotherapy; Japan; Phase III;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：485 / 493

页数：8

共 50 条

[31] Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis
Takemoto, Shinnosuke
Akagi, Kazumasa
Ono, Sawana
Tomono, Hiromi
Honda, Noritaka
Suyama, Takayuki
Umeyama, Yasuhiro
Dotsu, Yosuke
Taniguchi, Hirokazu
Ogawara, Daiki
Senju, Hiroaki
Gyotoku, Hiroshi
Sugasaki, Nanae
Yamaguchi, Hiroyuki
Nakatomi, Katsumi
Fukuda, Minoru
Mukae, Hiroshi
THORACIC CANCER, 2021, 12 (17) : 2300 - 2306
[32] Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy
Garon, Edward B.
Scagliotti, Giorgio Vittorio
Gautschi, Oliver
Reck, Martin
Thomas, Michael
Iglesias Docampo, Lara
Kalofonos, Haralabos
Kim, Joo-Hang
Gans, Steven
Brustugun, Odd Terje
Orlov, Sergey V.
Carter, Gebra Cuyun
Zimmermann, Annamaria H.
Oton, Ana B.
Alexandris, Ekaterine
Lee, Pablo
Wolff, Katharina
Stefaniak, Victoria Jennifer
Socinski, Mark A.
Perol, Maurice
ESMO OPEN, 2020, 5 (01)
[33] A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER
Goldman, Jonathan W.
Mazieres, Julien
Barlesi, Fabrice
Dragnev, Konstantin H.
Koczywas, Marianna
Goskel, Tuncay
Cortot, Alexis B.
Girard, Nicolas
Wesseler, Claas
Bischoff, Helge
Nadal, Ernest
Park, Keunchil
Lu, Shun
Taus, Alvaro
Cobo, Manuel
Estrem, Shawn T.
Wijayawardana, Sameera R.
Turner, Kellie
Oakley, Gerard Joseph, III
Hurt, Karla C.
Chiang, Alan Y.
Hossain, Anwar M.
John, William J.
Paz-Ares, Luis
FRONTIERS IN ONCOLOGY, 2020, 10
[34] Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials
Yu, Yong
Xu, Xun
Du, Ziyan
Shi, Minhua
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1265 - 1275
[35] Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer
Yamaguchi, Masafumi
Toyokawa, Gouji
Ohba, Taro
Sasaki, Tomonari
Kometani, Takuro
Hamatake, Motoharu
Hirai, Fumihiko
Taguchi, Kenichi
Yamanaka, Takeharu
Seto, Takashi
Takenoyama, Mitsuhiro
Sugio, Kenji
Ichinose, Yukito
ANNALS OF THORACIC SURGERY, 2013, 96 (05) : 1783 - 1789
[36] PHASE III TRIAL COMPARING CARBOPLATIN/S-1 TO CARBOPLATIN/PACLITAXEL IN TREATMENT-NAIVE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): SUBGROUP ANALYSIS AND UPDATED RESULTS OF THE LETS STUDY (WJTOG3605).
Satouchi, Miyako
Okamoto, Isamu
Morita, Satoshi
Yoshioka, Hiroshige
Takeda, Koji
Seto, Takashi
Yamamoto, Nobuyuki
Fukuoka, Masahiro
Hida, Toyoaki
Katakami, Nobuyuki
Saito, Hiroshi
Senba, Hiroshi
Tamura, Kenji
Yokota, Soichiro
Nakano, Takashi
Tanio, Yoshiro
Nakagawa, Kazuhiko
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S560 - S560
[37] Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice
Mattson, K
Bosquee, L
Dabouis, G
Le Groumellec, A
Pujol, JL
Marien, S
Stupp, R
Douillard, JY
Brägas, B
Berille, J
Olivares, R
Le Chevalier, T
LUNG CANCER, 2000, 29 (03) : 205 - 216
[38] Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
Sun, Xinchen
Li, Fan
Sun, Ning
Qin Shukui
Chen Baoan
Feng Jifeng
Lu, Cheng
Lu Zuhong
Cheng Hongyan
Cao YuanDong
Ji Jiazhong
Zhou Yingfeng
LUNG CANCER, 2009, 65 (02) : 230 - 236
[39] Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients
Qian, Lei
Ding, Xiao
Li, Fang-Qi
Tian, Hui-Min
Chen, Xiao
Han, Fu-Jun
Wang, Hong-Yi
Li, Wen-Qian
Niu, Chao
Xu, Jian-Ting
Li, Zhao-Zhi
He, Hua
Cui, Jiu-Wei
NEOPLASMA, 2023, 70 (02) : 251 - 259
[40] Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer
Urata, Yoshiko
Okamoto, Isamu
Takeda, Masayuki
Hattori, Yoshihiro
Okuno, Keiko
Shimada, Temiko
Kurata, Takayasu
Kaneda, Hiroyasu
Miyazaki, Masaki
Terashima, Masaaki
Tanaka, Kaoru
Morita, Satoshi
Nakagawa, Kazuhiko
Negoro, Shunichi
Satouchi, Miyako
CANCER, 2013, 119 (12) : 2275 - 2281

← 1 2 3 4 5 →